Pascal Biosciences Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Pascal Biosciences recent Real Value cannot be determined due to lack of data. The prevailing price of Pascal Biosciences is $0.0. Our model determines the value of Pascal Biosciences from analyzing the company fundamentals such as Shares Owned By Insiders of 5.08 %, ebitda of (1.07 M), and Return On Asset of -2.81 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support locking in undervalued entities and disposing overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Pascal Biosciences Total Value Analysis
Pascal Biosciences is at this time forecasted to have takeover price of 869.66 K with market capitalization of 1.01 M, debt of 215.65 K, and cash on hands of 16.91 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Pascal Biosciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
869.66 K | 1.01 M | 215.65 K | 16.91 K |
Pascal Biosciences Asset Utilization
One of the ways to look at asset utilization of Pascal is to check how much profit was generated for every dollar of assets it reports. Pascal Biosciences holds a negative application of assets of -2.81 pct., losing $0.0281 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Pascal Biosciences shows how discouraging it operates for each dollar spent on its assets.Pascal Biosciences Ownership Allocation
Pascal Biosciences owns a total of 65.59 Million outstanding shares. Pascal Biosciences holds 5.08 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pascal Biosciences Profitability Analysis
Net Loss for the year was (1.09 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Pascal Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Pascal Biosciences and how it compares across the competition.
Pascal Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pascal Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 65.1 M | |
| Retained Earnings | -14.3 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Pascal Biosciences information on this page should be used as a complementary analysis to other Pascal Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Pascal OTC Stock
If you are still planning to invest in Pascal Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pascal Biosciences' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |